bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc.BIAFEarnings & Financial Report

Nasdaq · Health Care · Services-Commercial Physical & Biological Research

bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.

Top Holders

Holder% OwnedSharesChangeAs of
Roby6.44%
603.1K
2023-10-10